Mimedx (MDXG) Cash from Investing Activities Growth (5y) (2016 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Cash from Investing Activities Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.52% |
| Mar 31, 2026 | -22.10% |
| Dec 31, 2025 | 31.81% |
| Sep 30, 2025 | -49.25% |
| Jun 30, 2025 | -12.79% |
| Mar 31, 2025 | 17.86% |
| Dec 31, 2024 | -28.39% |
| Sep 30, 2024 | -44.04% |
| Jun 30, 2024 | -22.36% |
| Mar 31, 2024 | -69.31% |
| Dec 31, 2023 | 16.51% |
| Sep 30, 2023 | 23.35% |
| Jun 30, 2023 | 32.45% |
| Mar 31, 2023 | 26.27% |
| Dec 31, 2022 | -6.37% |
| Sep 30, 2022 | 23.14% |
| Jun 30, 2022 | 24.76% |
| Mar 31, 2022 | 31.33% |
| Dec 31, 2021 | 23.91% |
| Sep 30, 2021 | 19.67% |